AARTI DRUGS
Back to Balance Sheet
|
AARTI DRUGS Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹249 Cr | ₹194 Cr | ₹185 Cr | ₹151 Cr | ₹88 Cr |
What is the latest Contingent Liabilities ratio of AARTI DRUGS ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹249 Cr |
Mar2023 | ₹194 Cr |
Mar2022 | ₹185 Cr |
Mar2021 | ₹151 Cr |
Mar2020 | ₹88 Cr |
How is Contingent Liabilities of AARTI DRUGS Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹249 Cr | 28.43 | |
Mar2023 | ₹194 Cr | 4.83 | |
Mar2022 | ₹185 Cr | 22.44 | |
Mar2021 | ₹151 Cr | 72.01 | |
Mar2020 | ₹88 Cr | - |
Compare Contingent Liabilities of peers of AARTI DRUGS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AARTI DRUGS | ₹4,569.6 Cr | -1.8% | -5.5% | -2.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹458,225.0 Cr | -0.6% | 1.3% | 65.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,941.0 Cr | -1.1% | 11.4% | 64% | Stock Analytics | |
CIPLA | ₹125,298.0 Cr | -2.3% | -6.8% | 33.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,631.0 Cr | 1.5% | 1% | 22.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹102,802.0 Cr | -4.2% | -8.1% | 72.3% | Stock Analytics |
AARTI DRUGS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AARTI DRUGS | -1.8% |
-5.5% |
-2.8% |
SENSEX | -0.7% |
-2.4% |
22% |
You may also like the below Video Courses